HPV positive pelvic cancer
Showing 1 - 25 of >10,000
Oropharynx Squamous Cell Carcinoma Trial (Blood sample)
Not yet recruiting
- Oropharynx Squamous Cell Carcinoma
- Blood sample
- (no location specified)
Jan 12, 2023
HPV-associated Oropharyngeal Cancer
Recruiting
- PREDICTIVE BIOMARKERS
- +2 more
- HPV-ASSOCIATED OROPHARYNGEAL CANCER
-
Rome, Italy"Regina Elena" National Cancer Institute
Oct 19, 2023
Head and Neck Carcinoma, Adult Disease Trial in Villejuif (HPVDC injection level dose 1, injection level dose 1, HPVDC
Recruiting
- Head and Neck Carcinoma
- Adult Disease
- HPVDC injection level dose 1
- +3 more
-
Villejuif, FranceGustave Roussy
Aug 17, 2023
HPV Positive Oropharyngeal Squamous Cell Carcinoma Trial in Boston (Blood test for HPV DNA)
Recruiting
- HPV Positive Oropharyngeal Squamous Cell Carcinoma
- Blood test for HPV DNA
-
Boston, MassachusettsBrigham and Women's Hospital
Jun 8, 2022
Cervical Cancer, Cervix Cancer, Cervix Tumor Trial in Sao Paulo (cisplatin, gemcitabine, Follow-up)
Not yet recruiting
- Cervical Cancer
- +2 more
- cisplatin, gemcitabine
- Follow-up
-
Sao Paulo, BrazilHospital do Coração - Research Institute
Mar 1, 2023
Cervical Precancer in HPV-positive Women
Recruiting
- HPV Infection
- Cervical Cancer
- HPV integration test
-
Wuhan, Hubei, ChinaTongji Hospital, Tongji Medical College Huazhong University of S
Oct 5, 2022
Self-collected Vaginal and Urine Samples in HIV-positive Women
Not yet recruiting
- HIV Infections
- +3 more
- Self-sampling for HPV infection
- (no location specified)
Mar 13, 2023
Head Neck Cancer, Squamous Cell Carcinoma of the Head and Neck, HPV Positive Oropharyngeal Squamous Cell Carcinoma Trial in New
Completed
- Head and Neck Cancer
- +2 more
- ADXS11-001 (ADXS-HPV)
-
New York, New York
- +1 more
Sep 9, 2022
Clinical Stage I HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8, Oropharyngeal HPV-Positive Squamous Cell Carcinoma
Recruiting
- Clinical Stage I HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8
- Oropharyngeal HPV-Positive Squamous Cell Carcinoma
- Radiation Therapy
-
Atlanta, Georgia
- +1 more
Jun 7, 2022
Cervical Cancer, Throat Cancer, Oropharynx Cancer Trial in New Brunswick (E7 TCR-T cells)
Not yet recruiting
- Cervical Cancer
- +20 more
- E7 TCR-T cells
-
New Brunswick, New Jersey
- +1 more
Jan 18, 2023
HPV-Associated Oropharyngeal Squamous Cell Carcinoma, HPV Positive Oropharyngeal Squamous Cell Carcinoma, HPV-Mediated
Recruiting
- HPV-Associated Oropharyngeal Squamous Cell Carcinoma
- +11 more
- NavDx HPV ctDNA Testing
- +2 more
-
Boston, Massachusetts
- +1 more
Jul 6, 2022
HPV, Oropharyngeal Cancer Trial in Houston (Balstilimab)
Not yet recruiting
- HPV
- Oropharyngeal Cancer
-
Houston, TexasM D Anderson Cancer Center
Dec 5, 2022
Clinical Stage I HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8, Clinical Stage II HPV-Mediated (p16-Positive)
Recruiting
- Clinical Stage I HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8
- +10 more
- Intensity-Modulated Radiation Therapy
- +4 more
-
Houston, TexasM D Anderson Cancer Center
Nov 8, 2022
Sinonasal Cancer, Squamous NSCLC, Lung Cancer Trial run by the National Cancer Institute (NCI) (pembrolizumab, valemetostat)
Not yet recruiting
- Sinonasal Cancer
- +5 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jun 5, 2023
Using Human Papillomavirus DNA Testing to Detect HPV-Related
Recruiting
- Oropharyngeal Cancer
- +2 more
- NavDx
-
Basking Ridge, New Jersey
- +6 more
Apr 3, 2023
Head Neck Cancer, Oropharynx Cancer, HPV Positive Oropharyngeal Squamous Cell Carcinoma Trial in Columbia (Cisplatin injection)
Recruiting
- Cancer of the Head and Neck
- +3 more
- Cisplatin injection
-
Columbia, MissouriUniversity of Missouri
Oct 31, 2022
HPV-Related Cervical Carcinoma, HPV-Related Malignancy, Cervical Cancer Trial (VB10.16, Atezolizumab Injection [Tecentriq],
Not yet recruiting
- HPV-Related Cervical Carcinoma
- +2 more
- VB10.16
- +2 more
- (no location specified)
Oct 24, 2023
Cervical Cancer, Head and Neck Squamous Cell Carcinoma, Oropharyngeal Cancer Trial in Shanghai (Fludarabine + Cyclophosphamide,
Not yet recruiting
- Cervical Cancer
- +6 more
- Fludarabine + Cyclophosphamide
- HRYZ-T101 TCR-T Cell
-
Shanghai, Shanghai, ChinaFudan University Shanghai Cancer Center
Mar 27, 2023
De-escaLated Head and Neck Irradiation in HPV positivE
Recruiting
- Oropharyngeal Cancer
-
Fargo, North Dakota
- +1 more
Nov 14, 2022
Malignant Tumors of Ill-defined Secondary and Unspecified Sites, Malignant Tumors of Lip Oral Cavity and Pharynx, Oropharyngeal
Terminated
- Malignant Neoplasms of Ill-defined Secondary and Unspecified Sites
- +2 more
- Utomilumab
- ISA101b
-
Houston, TexasUniversity of Texas MD Anderson Cancer Center
Nov 22, 2022
HPV Positive Oropharyngeal Squamous Cell Carcinoma Trial in United States (Cisplatin-based Radiation Therapy, Cisplatin
Recruiting
- HPV Positive Oropharyngeal Squamous Cell Carcinoma
- Cisplatin-based Radiation Therapy
- Cisplatin Chemotherapy
-
Beverly Hills, California
- +3 more
Jul 6, 2022
HPV Positive Oropharyngeal Squamous Cell Carcinoma Trial in Orange (Intensity-Modulated Radiation Therapy (IMRT))
Recruiting
- HPV Positive Oropharyngeal Squamous Cell Carcinoma
- Intensity-Modulated Radiation Therapy (IMRT)
-
Orange, CaliforniaChao Family Comprehensive Cancer Center, University of Californi
Nov 4, 2022
Head Neck Cancer, Cervical Cancer, Non-small Cell Carcinoma Trial in Scottsdale, Chapel Hill (TSC-204-A0201, TSC-204-C0702,
Not yet recruiting
- Head and Neck Cancer
- +20 more
- TSC-204-A0201
- +4 more
-
Scottsdale, Arizona
- +1 more
Aug 3, 2023
Head and Neck Squamous Cell Carcinoma Trial in Seoul (nivolumab-GX-188E-GX-I7)
Not yet recruiting
- Head and Neck Squamous Cell Carcinoma
-
Seoul, Korea, Republic ofYonsei University Health System, Severance Hospital
Apr 20, 2022
Head and Neck Squamous Cell Carcinoma, Melanoma, Cervical Cancer Trial in United States (RPTR-168)
Terminated
- Head and Neck Squamous Cell Carcinoma
- +2 more
- RPTR-168
-
Scottsdale, Arizona
- +3 more
Dec 2, 2022